Palogic Value Management’s Johnson & Johnson JNJ Stock Holding History

Palogic Value Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$598K	Hold	2,354	–	–	0.2%	120
2026 Q1	$575K	Buy	2,354 +675	+40%	+$157K	0.24%	112
2025 Q4	$347K	Hold	1,679	–	–	0.14%	131
2025 Q3	$311K	Hold	1,679	–	–	0.13%	137
2025 Q2	$256K	Hold	1,679	–	–	0.1%	143
2025 Q1	$278K	Hold	1,679	–	–	0.12%	132
2024 Q4	$243K	Hold	1,679	–	–	0.09%	147
2024 Q3	$272K	Hold	1,679	–	–	0.09%	150
2024 Q2	$245K	Hold	1,679	–	–	0.1%	139
2024 Q1	$266K	Hold	1,679	–	–	0.11%	134
2023 Q4	$263K	Hold	1,679	–	–	0.12%	131
2023 Q3	$262K	Hold	1,679	–	–	0.12%	127
2023 Q2	$278K	Sell	1,679 -100	-6%	-$16.1K	0.13%	128
2023 Q1	$276K	Hold	1,779	–	–	0.14%	132
2022 Q4	$314K	Buy	+1,779	New	+$307K	0.16%	119

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Palogic Value Management's JNJ Position: Q2 2026 in Review

Palogic Value Management held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 2,354 shares worth $598K. The position accounts for 0.2% of the portfolio, ranked #120.

Palogic Value Management first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Palogic Value Management held 2,354 shares of Johnson & Johnson worth $598K as of Q2 2026.
Palogic Value Management left its Johnson & Johnson share count unchanged in Q2 2026.
Johnson & Johnson made up 0.2% of Palogic Value Management's portfolio in Q2 2026, its #120 holding.
Palogic Value Management first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Palogic Value Management's 13F filing for Q2 2026, filed 14 Aug 2026.